Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care: A Randomized Controlled Non-Inferiority Multicenter Trial

NCT07236944 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT07236944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07236944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care: A Randomized Controlled Non-Inferiority Multicenter Trial
Lead sponsor
Uppsala University
Phase
Phase 4
Overall status
Recruiting
Start date
December 31, 2025
Completion date
March 31, 2029
Enrollment
560 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

febrile urinary tract infection